Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ETR vs GSK✓SelectedUSD · GSKETR vs GSK performance historyLatest closeAs of-1.70%11/20
Stock and ETF performance explorer

ETR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+130.9%
GSK return
+40.7%
Excess return
+90.2%
Maximum drawdown
-25.1%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.7%-0.1%-1.6%-1.7%
7D-6.1%-5.3%-0.8%-5.1%
30D-1.0%-3.7%+2.7%-0.3%
3M-2.2%-7.3%+5.1%-0.8%
6M-5.6%-4.2%-1.4%-5.0%
YTD+15.7%+0.9%+14.8%+14.8%
1Y+14.5%+7.3%+7.3%+12.3%
3Y+131.2%+52.7%+78.5%+104.8%
All+130.9%+40.7%+90.2%+90.3%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling